137 related articles for article (PubMed ID: 32552139)
1. COVID-19 in a Patient with β-Thalassemia Major and Severe Pulmonary Arterial Hypertension.
Pinto VM; Derchi GE; Bacigalupo L; Pontali E; Forni GL
Hemoglobin; 2020 May; 44(3):218-220. PubMed ID: 32552139
[TBL] [Abstract][Full Text] [Related]
2. Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: Friend or foe?
Badagliacca R; Sciomer S; Petrosillo N
J Heart Lung Transplant; 2020 Jul; 39(7):729-730. PubMed ID: 32360293
[No Abstract] [Full Text] [Related]
3. Blocking angiotensin earlier with RAS blockers, statins, and heparin in high-risk COVID-19 patients: Is the remedy here?
Eroğlu I; Çelik Eroğlu B; Uyaroğlu OA; Sain Güven G
Anatol J Cardiol; 2020 Jul; 24(1):19-20. PubMed ID: 32628145
[No Abstract] [Full Text] [Related]
4. Clinical course of COVID-19 in pulmonary arterial hypertension patients.
Nuche J; Pérez-Olivares C; Segura de la Cal T; Jiménez López-Guarch C; Arribas Ynsaurriaga F; Escribano Subías P
Rev Esp Cardiol (Engl Ed); 2020 Sep; 73(9):775-778. PubMed ID: 32540421
[No Abstract] [Full Text] [Related]
5. Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis.
Guo X; Zhu Y; Hong Y
Hypertension; 2020 Aug; 76(2):e13-e14. PubMed ID: 32458694
[No Abstract] [Full Text] [Related]
6. A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19.
Wang Z; Zhang D; Wang S; Jin Y; Huan J; Wu Y; Xia C; Li Z; Qi X; Zhang D; Han X; Zhu X; Qu Y; Wang Q
Med Sci Monit; 2020 Sep; 26():e926651. PubMed ID: 32969367
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin receptor blockers for the treatment of COVID-19 and its comorbidities.
Saavedra JM
Pharmacol Res; 2020 Sep; 159():104958. PubMed ID: 32473311
[No Abstract] [Full Text] [Related]
8. Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme inhibitors and Angiotensin II Receptor Blockers, in a sample of infected Italian citizens.
Bravi F; Flacco ME; Carradori T; Volta CA; Cosenza G; De Togni A; Acuti Martellucci C; Parruti G; Mantovani L; Manzoli L
PLoS One; 2020; 15(6):e0235248. PubMed ID: 32579597
[TBL] [Abstract][Full Text] [Related]
9. A consensus statement on the use of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in relation to COVID-19 (corona virus disease 2019).
Talreja H; Tan J; Dawes M; Supershad S; Rabindranath K; Fisher J; Valappil S; van der Merwe V; Wong L; van der Merwe W; Paton J
N Z Med J; 2020 Apr; 133(1512):85-87. PubMed ID: 32242182
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin II Receptor Blockers: A Comparison of Outcomes in Patients With COVID-19.
Kalra A; Hawkins ES; Nowacki AS; Jain V; Milinovich A; Saef J; Thomas G; Gebreselassie SK; Karnik SS; Jehi L; Young JB; Svensson LG; Chung MK; Mehta N
Circ Cardiovasc Qual Outcomes; 2020 Oct; 13(10):e007115. PubMed ID: 32856462
[No Abstract] [Full Text] [Related]
11. Thalassemic Child Presenting with Anosmia due to COVID-19.
Marhaeni W; Wijaya AB; Kusumaningtyas P; Mapianto RS
Indian J Pediatr; 2020 Sep; 87(9):750. PubMed ID: 32519260
[No Abstract] [Full Text] [Related]
12. Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China.
Li J; Wang X; Chen J; Zhang H; Deng A
JAMA Cardiol; 2020 Jul; 5(7):825-830. PubMed ID: 32324209
[TBL] [Abstract][Full Text] [Related]
13. Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology.
Dal Moro F; Livi U
Clin Immunol; 2020 May; 214():108414. PubMed ID: 32272196
[No Abstract] [Full Text] [Related]
14. The COVID-19 Pandemic and Mayo Clinic Proceedings.
Nath KA
Mayo Clin Proc; 2020 May; 95(5):835-836. PubMed ID: 32370843
[No Abstract] [Full Text] [Related]
15. [Scientific statement on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19].
;
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):565-566. PubMed ID: 32842268
[TBL] [Abstract][Full Text] [Related]
16. Related molecular mechanisms of COVID-19, hypertension, and diabetes.
Akkus E; Sahin M
Am J Physiol Endocrinol Metab; 2020 Jun; 318(6):E881. PubMed ID: 32479159
[No Abstract] [Full Text] [Related]
17. Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study.
Yang G; Tan Z; Zhou L; Yang M; Peng L; Liu J; Cai J; Yang R; Han J; Huang Y; He S
Hypertension; 2020 Jul; 76(1):51-58. PubMed ID: 32348166
[TBL] [Abstract][Full Text] [Related]
18. The war against the SARS-CoV2 infection: Is it better to fight or mitigate it?
Dal Moro F; Vendramin I; Livi U
Med Hypotheses; 2020 Oct; 143():110129. PubMed ID: 32721814
[TBL] [Abstract][Full Text] [Related]
19. Associations Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blocker Use, Gastrointestinal Symptoms, and Mortality Among Patients With COVID-19.
Tan ND; Qiu Y; Xing XB; Ghosh S; Chen MH; Mao R
Gastroenterology; 2020 Sep; 159(3):1170-1172.e1. PubMed ID: 32422208
[No Abstract] [Full Text] [Related]
20. COVID-19, Angiotensin Receptor Blockers, and the Brain.
Saavedra JM
Cell Mol Neurobiol; 2020 Jul; 40(5):667-674. PubMed ID: 32385549
[No Abstract] [Full Text] [Related]
[Next] [New Search]
